X4 Pharmaceuticals, Inc.XFORNASDAQ
Loading
Price to Sales: Discounted ValuationCompressed
Percentile Rank80
5Y CAGR-35.5%
Year-over-Year Change
Price-to-sales ratio
5Y CAGR
-35.5%/yr
Long-term compound
Percentile
P80
Within normal range
vs 5Y Ago
0.1x
Contraction
Streak
1 yr
Consecutive declineCompressed
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 4.82 | -91.6% |
| 2024 | 57.69 | - |
| 2023 | 0.00 | - |
| 2022 | 0.00 | - |
| 2021 | 0.00 | -100.0% |
| 2020 | 43.03 | - |
| 2019 | 0.00 | - |
| 2018 | 0.00 | - |
| 2017 | 0.00 | - |
| 2016 | 0.00 | - |